ARTICLE | Clinical News
FluGEM: Phase I started
March 28, 2011 7:00 AM UTC
Mucosis began a single-blind, placebo-controlled, Dutch Phase I trial to evaluate intranasal and intramuscular injections of FluGEM in 90 healthy adults ages 18-49. After an interim safety analysis, t...